Опухоли женской репродуктивной системы (Jul 2014)

Ten-year adjuvant hormone therapy for breast cancer: the pros and cons (a review of literature)

  • S. M. Portnoy,
  • T. A. Shendrikova

DOI
https://doi.org/10.17650/1994-4098-2013-0-3-4-50-53
Journal volume & issue
Vol. 0, no. 3-4
pp. 50 – 53

Abstract

Read online

Tamoxifen is one of the basic drugs of adjuvant hormone therapy in patients with hormone-dependent breast tumors. The purpose of this paper is to analyze the results of randomized trials of long-term adjuvant hormone therapy for breast cancer.

Keywords